Email This Article
Protein Design Says Zamyl Failed Tests
By
Adam Feuerstein
05/19/02 - 03:36 PM EDT
The leukemia drug didn't do well enough to pass the test with the FDA.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,413.54 | 1,113.39 | 2,235.87 | 36.82 |
Oil *
72.64
|
|
UP
84.65
|
UP
10.92
|
UP
24.18
|
UP
1.36
|
10 Yr
3.68%
SPDR Gold
107.02
|
|
+0.82%
|
+0.99%
|
+1.09%
|
+3.84%
|
Data delayed 20 minutes |
Connect with TheStreet